Multiple sclerosis, often shortened to 'MS', is a long-lasting chronic disease of the central nervous system. There is ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...

Since being diagnosed with multiple sclerosis (MS) in 2018, Blair has emerged as a fierce advocate for those living with ...

Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a diversified, vertically integrated global healthcare ...

A young woman has taken to social media to bring awareness to Multiple sclerosis, often shortened to 'MS' after having been ...

Neuraxpharm Ireland, part of Neuraxpharm Group, a leading European speciality pharmaceutical company focused on the treatment ...

Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...

Recent research highlights a concerning trend: pregnant people with multiple sclerosis are more prone to mental illnesses ...

Sales of an Alzheimer’s disease treatment were better than expected, but that and a quarterly beat wasn’t enough to offset ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...